| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 4e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |